Elysium Health
Only brand combining NR with pterostilbene in a single capsule for synergistic sirtuin activation, backed by a Nobel Prize-winning scientific advisory board and published clinical trial
NOT CLEARED
No FDA clearance, registration, or CE marking found.
Key facts at a glance.
- Founded
- 2014
- Headquarters
- New York, NY, USA
- Price range
- $1.67–$1.67
- Trustpilot
- 3.4 / 5 (13)
The real price over three years.
Total cost of ownership · 3yr
| Hardwareone-time | $1.67 |
| 3-year total | $1.67 |
What the device does.
- + Basis: proprietary NR + pterostilbene combination
- + Clinically proven to increase NAD+ by 40% within 30 days
- + NSF Certified for Sport
- + Co-founded by MIT aging researcher Leonard Guarente
- + Third-party tested during and after manufacture
- + Vegan, gluten-free, nut-free formula
- + Index biological age test (at-home epigenetic testing)
- + Published peer-reviewed clinical trial (NRPT study)
The trade-offs.
- + **Only brand combining NR with pterostilbene** in single capsule for synergistic sirtuin activation
- + **Nobel Prize-winning scientific advisory board** — strongest academic credentials in supplement category
- + Published clinical trial backing
- + 2014-founded with established longevity-supplement market presence
- + Same parent company as Elysium Index biological-age test (ecosystem cohesion)
- − **Trustpilot 3.4/5 from 13 reviews** — small-sample mid-tier consumer signal
- − $1.67/serving accessible but not cheapest (DoNotAge $0.20)
- − NR vs NMN methodology debate (some NMN-aligned biohackers prefer NMN)
- − Smaller brand awareness vs Tru Niagen (the dominant NR specialist)
- − Pterostilbene synergy claims have research support but vary by individual
Science-minded consumers 40+, professionals willing to pay premium for research-backed longevity solutions
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
Elysium Health Basis is the NR + pterostilbene combination specialist with Nobel-Prize-winning scientific advisory board — founded 2014 in NYC, with structural value claim built on only brand combining NR (nicotinamide riboside) with pterostilbene in single capsule for synergistic sirtuin activation + Nobel Prize-winning scientific advisory board + published clinical trial backing + ecosystem cohesion with Elysium Index biological-age test (same parent company).
The structural editorial caveats: Trustpilot 3.4/5 from only 13 reviews small-sample mid-tier signal, $1.67/serving accessible but not cheapest (DoNotAge $0.20), NR vs NMN methodology debate (NMN-aligned biohackers may prefer alternatives), and smaller brand awareness vs Tru Niagen (the dominant NR specialist via ChromaDex).
When Elysium Health Basis Makes Sense
Strong fit: NR + pterostilbene combination preference; Nobel-Prize scientific advisory board credibility priority; Elysium Index biological-age test ecosystem users; users wanting published-clinical-trial-backed longevity supplement.
Weaker fit: NMN preference (Renue, ProHealth, Double Wood, DoNotAge); cheapest cost-per-serving (DoNotAge $0.20); largest NR-specialist brand awareness (Tru Niagen); largest Trustpilot review base.
3-Year Cost of Ownership
| Use case | Cost |
|---|---|
| Elysium Basis ($1.67/serving) | ~$610/yr at 1 serving/day = $1,830 / 3 yr |
Compare: Tru Niagen NR 300mg (~$540/yr), DoNotAge NMN ($240/yr at $0.20/serving), ProHealth NMN Pro 500mg ($540-720/yr subscribed), Renue liposomal NMN ($540-1,080/yr).
Verdict: Recommended
Elysium Health Basis earns a recommended verdict on its only-brand NR + pterostilbene combination for synergistic sirtuin activation, Nobel Prize-winning scientific advisory board (strongest academic credentials in longevity supplement category), published clinical trial backing, 2014-founded established positioning, and ecosystem cohesion with Elysium Index biological-age test — balanced against Trustpilot 3.4/5 small-sample mid-tier signal, not cheapest per-serving, NR-vs-NMN methodology debate, and smaller brand awareness vs Tru Niagen.
For NR + pterostilbene combination users prioritizing Nobel-Prize academic credibility + Elysium ecosystem alignment, structurally distinctive. For NMN preference, cheapest cost, or largest brand awareness, alternatives are better matched.
Changelog
- 2026-05-07: Initial review published based on Elysium Health Basis published specifications.
What we'll measure on the bench.
- Protocol
- Third-party purity assay (NSF / USP)
- Primary metric
- Active compound % vs label claim
- Pass threshold
- within ±10% of label · contaminants below FDA limits
- Session shape
- 3 bottles from 3 channels, paired assay
§ Bench session pending. Measured values will replace this panel as the protocol completes — see Plate VI · Methodology for the full testing rulebook.